Back to Articles

Salicylate Acid ( Aspirin ) Protocol

Salicylate Acid ( Aspirin ) Protocol

Salicylate Management Protocol


1. ER Assessment

Unstable Patient

  • ABCD assessment

Stable Patient

  • Proceed to decontamination and investigations

2. Decontamination

  • Gastric Lavage up to 6 hours post-ingestion
  • Activated charcoal 1 gm/kg, then MDAC 0.5 gm/kg / 4 h for 24 hours

3. Investigations

  • Salicylate blood level (4hrs)
  • CBC, PT, PTT, INR, ABG, electrolytes, glucose, KFT, LFT
  • Chest X-ray if there is hypoxemia
  • Repeat salicylate blood level every 4 hours until fall <15

4. Clinical Classification

Moderate & Severe Cases

  • Altered mental status, seizures
  • Metabolic acidosis or respiratory alkalosis
  • Dehydration
  • Pulmonary oedema
  • OR SBL > 90 mg/dL
  • → ICU Admission

Mild Cases

  • Tinnitus & vomiting & salicylate > 30
  • → In-patient admission

Asymptomatic Cases

  • SBL ≤ 15 mg/dL
  • Normal pH
  • → Repeat salicylate level after 6h if < 15

5. Alkalinization of Urine

Protocol:

  • Initial IV bolus of NaHCO₃ 1–2 mEq/kg then
  • NaHCO₃ infusions: 100–150 mEq in 1 liter D5% at 150–200 ml/h (or about twice the maintenance requirements in a child)

Goals of Urinary Alkalization:

  • Keep urinary pH 7.5–8
  • Blood pH not > 7.55

Monitoring during Alkalinization:

  • Salicylate level / 4 h
  • ABG / 4 h
  • Electrolyte / 4 h
  • Urinary pH / 4 hrs
  • UOP: 3–5 ml/kg/hr
  • Correct hypokalaemia by 40 mEq KCL /L to keep K level at 4–4.5 mEq/L
  • Correct hypocalcaemia with calcium gluconate IV (5–10 ml in adults)

Contraindications:

  • Renal failure
  • ALI
  • CHF cerebral edema

Continue alkaline diuresis until salicylate level < 30 mg/dL


6. Discharge Criteria

  • Patient is asymptomatic
  • SBL < 15 mg/dL
  • Normal ABG & electrolytes

7. Indications for Hemodialysis

  • Acute toxicity with SBL > 90 mg/dL
  • CHF, ARDS, renal failure, coma or seizures
  • Refractory AB disturbance
  • Hepatic compromise with coagulopathy

Note: Combination with alkalinization (if not contraindicated) achieves rapid initial reduction of salicylate level.